Company profile PDSB
After 39 days of this quarter the interest is at 56.0. Based on that we can calculate that during remaining 52 days it will total up to 131.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 109 | 123 12.8% QoQ | 94 -23.6% QoQ | 168 78.7% QoQ |
| 2020 | 65 -40.4% YoY -61.3% QoQ | 171 39.0% YoY 163.1% QoQ | 324 244.7% YoY 89.5% QoQ | 130 -22.6% YoY -59.9% QoQ |
| 2021 | 190 192.3% YoY 46.2% QoQ | 254 48.5% YoY 33.7% QoQ | 108 -66.7% YoY -57.5% QoQ | 61 -53.1% YoY -43.5% QoQ |
| 2022 | 137 -27.9% YoY 124.6% QoQ | 125 -50.8% YoY -8.8% QoQ | 91 -15.7% YoY -27.2% QoQ | 161 163.9% YoY 76.9% QoQ |
| 2023 | 162 18.2% YoY 0.6% QoQ | 214 71.2% YoY 32.1% QoQ | 121 33.0% YoY -43.5% QoQ | 125 -22.4% YoY 3.3% QoQ |
| 2024 | 56 -65.4% YoY -55.2% QoQ | - | - | - |
The average 5 years interest of PDS Biotechnology was 11.45 per week. The last year interest of PDS Biotechnology compared to the last 5 years has changed by -6.81%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 12.32%.
After 39 days of this quarter the interest is at 56.0. Based on that we can calculate that during remaining 52 days it will total up to 131.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 109 | 123 12.8% QoQ | 94 -23.6% QoQ | 168 78.7% QoQ |
| 2020 | 65 -40.4% YoY -61.3% QoQ | 171 39.0% YoY 163.1% QoQ | 324 244.7% YoY 89.5% QoQ | 130 -22.6% YoY -59.9% QoQ |
| 2021 | 190 192.3% YoY 46.2% QoQ | 254 48.5% YoY 33.7% QoQ | 108 -66.7% YoY -57.5% QoQ | 61 -53.1% YoY -43.5% QoQ |
| 2022 | 137 -27.9% YoY 124.6% QoQ | 125 -50.8% YoY -8.8% QoQ | 91 -15.7% YoY -27.2% QoQ | 161 163.9% YoY 76.9% QoQ |
| 2023 | 162 18.2% YoY 0.6% QoQ | 214 71.2% YoY 32.1% QoQ | 121 33.0% YoY -43.5% QoQ | 125 -22.4% YoY 3.3% QoQ |
| 2024 | 56 -65.4% YoY -55.2% QoQ | - | - | - |
The average 5 years interest of PDS Biotechnology was 11.45 per week. The last year interest of PDS Biotechnology compared to the last 5 years has changed by -6.81%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 12.32%.
After 39 days of this quarter the interest is at 54.0. Based on that we can calculate that during remaining 52 days it will total up to 126.0. PDSB stock expected interest is significantly lower compared to same quarter last year (-50.8%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 50 | 31 -38.0% QoQ | 0 -100.0% QoQ | 92 inf% QoQ |
| 2020 | 40 -20.0% YoY -56.5% QoQ | 326 951.6% YoY 715.0% QoQ | 351 inf% YoY 7.7% QoQ | 194 110.9% YoY -44.7% QoQ |
| 2021 | 422 955.0% YoY 117.5% QoQ | 659 102.1% YoY 56.2% QoQ | 516 47.0% YoY -21.7% QoQ | 308 58.8% YoY -40.3% QoQ |
| 2022 | 154 -63.5% YoY -50.0% QoQ | 135 -79.5% YoY -12.3% QoQ | 138 -73.3% YoY 2.2% QoQ | 293 -4.9% YoY 112.3% QoQ |
| 2023 | 256 66.2% YoY -12.6% QoQ | 294 117.8% YoY 14.8% QoQ | 103 -25.4% YoY -65.0% QoQ | 148 -49.5% YoY 43.7% QoQ |
| 2024 | 54 -78.9% YoY -63.5% QoQ | - | - | - |
The average 5 years interest of PDSB stock was 17.49 per week. The last year interest of PDSB stock compared to the last 5 years has changed by -20.81%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 257.88%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. PDSB news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 84 | 114 35.7% QoQ | 46 -59.6% QoQ | 202 339.1% QoQ |
| 2020 | 91 8.3% YoY -55.0% QoQ | 66 -42.1% YoY -27.5% QoQ | 260 465.2% YoY 293.9% QoQ | 144 -28.7% YoY -44.6% QoQ |
| 2021 | 271 197.8% YoY 88.2% QoQ | 75 13.6% YoY -72.3% QoQ | 58 -77.7% YoY -22.7% QoQ | 295 104.9% YoY 408.6% QoQ |
| 2022 | 129 -52.4% YoY -56.3% QoQ | 109 45.3% YoY -15.5% QoQ | 0 -100.0% YoY -100.0% QoQ | 36 -87.8% YoY inf% QoQ |
| 2023 | 86 -33.3% YoY 138.9% QoQ | 131 20.2% YoY 52.3% QoQ | 195 inf% YoY 48.9% QoQ | 83 130.6% YoY -57.4% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of PDSB news was 9.48 per week. The last year interest of PDSB news compared to the last 5 years has changed by -10.55%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -5.78%.
There is not enough data for PDSB clinical trials to provide analysis
There is not enough data for PDSB clinical trials to provide correlation calculation
There is not enough data for PDSB clinical trials to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. PDS0101 expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 125 | 205 64.0% QoQ | 32 -84.4% QoQ | 35 9.4% QoQ |
| 2020 | 47 -62.4% YoY 34.3% QoQ | 29 -85.9% YoY -38.3% QoQ | 64 100.0% YoY 120.7% QoQ | 33 -5.7% YoY -48.4% QoQ |
| 2021 | 164 248.9% YoY 397.0% QoQ | 130 348.3% YoY -20.7% QoQ | 107 67.2% YoY -17.7% QoQ | 82 148.5% YoY -23.4% QoQ |
| 2022 | 37 -77.4% YoY -54.9% QoQ | 69 -46.9% YoY 86.5% QoQ | 115 7.5% YoY 66.7% QoQ | 64 -22.0% YoY -44.3% QoQ |
| 2023 | 53 43.2% YoY -17.2% QoQ | 77 11.6% YoY 45.3% QoQ | 90 -21.7% YoY 16.9% QoQ | 109 70.3% YoY 21.1% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of PDS0101 was 6.39 per week. The last year interest of PDS0101 compared to the last 5 years has changed by -11.58%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -30.84%.
There is not enough data for PDS Biotech cancer immunotherapies to provide analysis
There is not enough data for PDS Biotech cancer immunotherapies to provide correlation calculation
There is not enough data for PDS Biotech cancer immunotherapies to provide analysis
There is not enough data for PDS Biotech HPV treatment to provide analysis
There is not enough data for PDS Biotech HPV treatment to provide correlation calculation
There is not enough data for PDS Biotech HPV treatment to provide analysis
There is not enough data for PDS Biotech COVID-19 vaccine to provide analysis
There is not enough data for PDS Biotech COVID-19 vaccine to provide correlation calculation
There is not enough data for PDS Biotech COVID-19 vaccine to provide analysis
There is not enough data for PDS Biotech influenza vaccine to provide analysis
There is not enough data for PDS Biotech influenza vaccine to provide correlation calculation
There is not enough data for PDS Biotech influenza vaccine to provide analysis